Spaulding Clinical Research, LLC has notified the Attorney General of Massachusetts about a recent data breach where an unauthorized party gained access to parts of its computer network, compromising consumers’ sensitive information like names and Social Security numbers. Following the breach, Spaulding Clinical initiated an investigation and began sending data breach notification letters to affected individuals.
The Spaulding Clinical Research data breach, which was detected on November 8, 2023, involved suspicious activity within its IT network. After securing the network and conducting a thorough investigation with cybersecurity experts, it was confirmed that unauthorized access had occurred, exposing confidential information. Spaulding Clinical took steps to assess the leaked data, identifying compromised files and impacted consumers, with this process being completed on February 8, 2024.
Spaulding Clinical Research, LLC, a reputable Phase I clinical pharmacology unit based in Bend, Wisconsin, specializes in various studies related to clinical pharmacology and safety, offering a range of services including study design, medical writing, data management, and more. With a dedicated team of over 112 employees and an annual revenue of around $22 million, the company is committed to addressing the data breach incident transparently by informing affected individuals about the compromised information and providing necessary support and guidance
